Clinical Trial Update: Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study [NA]

View source ↗

Summary

This clinical trial evaluated multiparametric PET-MRI to study tumor heterogeneity in non-small cell lung cancer, but the pilot study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: NSCLC | NA | Status: TERMINATED